LV, L.,
ZHANG, L.,
LI, R.,
LI, Y.,
YANG, R.,
LI, C.,
FANG, R.,
SHABANOVA, A.,
LI, X.,
LIU, Y.,
LIANG, H.,
ZHOU, Y.,
SHAN, H.,
ZHENG, N. (2020) therapies and drugs have a good effect on cardiac conduction delay. Metformin (Met) has a protective effect
Baltina, L.A.,
Hour, M.-J.,
Liu, Y.-C.,
Chang, Y.-S.,
Huang, S.-H.,
Lai, H.-C.,
Kondratenko, R.M.,
Petrova, S.F.,
Yunusov, M.S.,
Lin, C.-W. (2021) . Currently, there are no licensed vaccines or specific post-infectious
therapies for ZIKV infection
Idrisov, Bulat,
Lunze, Karsten,
Cheng, Debbie M.,
Elena Blokhina,
Gnatienko, Natalia,
Quinn, Emily,
Bridden, Carly,
Walley, Alexander Y.,
Bryant, Kendall J.,
Lioznov, Dmitry,
Krupitsky, Evgeny,
Samet, Jefrey H. (2017) care (e.g., linkage to care, prescribed
antiretroviral
therapy [ART], and achieving HIV viral
Конъюктивит COVID-19 с осложненным течением. Случай из практикиBabushkin, Alexander E.,
Matyukhina, Ekaterina N.,
Saitova, Gulnaz R.,
Israfilova, Gulnara Z.,
Бабушкин, А.Э.,
Матюхина, Е.Н.,
Саитова, Г.Р.,
Исрафилова, Г.З. (2023) solutions of glucocorticosteroid, a cytostatic and an antiseptic combined with tear replacement
therapy in the general population is probable. The methods of NF1
therapy that are under investigation may become
Shnayder, N.A.,
Grechkina, V.V.,
Khasanova, A.K.,
Bochanova, E.N.,
Dontceva, E.A.,
Petrova, M.M.,
Asadullin, A.R.,
Shipulin, G.A.,
Altynbekov, K.S.,
Al-Zamil, M.,
Nasyrova, R.F. (2023) -modifying
therapy for multiple tumors, neurodegenerative diseases (Huntington’s disease, Parkinson’s disease
Mead, Gillian E,
Sposato, Luciano A,
Sampaio Silva, Gisele,
Yperzeele, Laetitia,
Wu, Simiao,
Kutlubaev, Mansur,
Cheyne, Joshua,
Wahab, Kolawole,
Urrutia, Victor C,
Sharma, Vijay K,
Sylaja, PN,
Hill, Kelvin,
Steiner, Thorsten,
David S, Liebeskind,
Rabinstein, lejandro A (2023) for reperfusion
therapies for acute ischemic stroke. For secondary prevention, strong recommendations included